Gene · 4600
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| pUL36 Deubiquitinase Activity Augments Both the Initiation and the Progression of Lytic Herpes Simplex Virus Infection in IFN-Primed Cells. | J Virol | 2022 | 36314822 | PubTator, text mining | PubMed |
| Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. | mBio | 2022 | 36314791 | PubTator, text mining | PubMed |
| IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding. | Front Oncol | 2022 | 36313631 | PubTator, text mining | PubMed |
| The functional role of p38 MAPK pathway in malignant brain tumors. | Front Pharmacol | 2022 | 36299892 | PubTator, text mining | PubMed |
| Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection. | Viruses | 2022 | 36298734 | PubTator, text mining | PubMed |
| Sensitivity Enhancement of Hybrid Two-Dimensional Nanomaterials-Based Surface Plasmon Resonance Biosensor. | Biosensors (Basel) | 2022 | 36290947 | PubTator, text mining | PubMed |
| Fentanyl enhances HIV infection in vitro. | Virology | 2022 | 36279602 | PubTator, text mining | PubMed |
| Integrated pathological analysis to develop a Gal-9 based immune survival stratification to predict the outcome of lung large cell neuroendocrine carcinoma and its usefulness in immunotherapy. | Int J Biol Sci | 2022 | 36263183 | PubTator, text mining | PubMed |
| Analysis of gene expression profiles to study malaria vaccine dose efficacy and immune response modulation. | Genomics Inform | 2022 | 36239109 | PubTator, text mining | PubMed |
| Facile hydrothermal synthesis of layered 1T' MoTe2 nanotubes as robust hydrogen evolution electrocatalysts. | Front Chem | 2022 | 36238098 | PubTator, text mining | PubMed |
| Enhanced Hydrogen Evolution Reactivity of T'-Phase Tungsten Dichalcogenides (WS2, WSe2, and WTe2) Materials: A DFT Study. | Int J Mol Sci | 2022 | 36233027 | PubTator, text mining | PubMed |
| A Novel Missense Mutation in ERCC8 Co-Segregates with Cerebellar Ataxia in a Consanguineous Pakistani Family. | Cells | 2022 | 36231052 | PubTator, text mining | PubMed |
| Modulation of Alveolar Macrophages by Postimmunobiotics: Impact on TLR3-Mediated Antiviral Respiratory Immunity. | Cells | 2022 | 36230948 | PubTator, text mining | PubMed |
| Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence. | Cells | 2022 | 36230929 | PubTator, text mining | PubMed |
| Marine-Sulfated Polysaccharides Extracts Exhibit Contrasted Time-Dependent Immunomodulatory and Antiviral Properties on Porcine Monocytes and Alveolar Macrophages. | Animals (Basel) | 2022 | 36230315 | PubTator, text mining | PubMed |
| Mitochondrial fitness and cancer risk. | PLoS One | 2022 | 36223343 | PubTator, text mining | PubMed |
| An anti-influenza combined therapy assessed by single cell RNA-sequencing. | Commun Biol | 2022 | 36216966 | PubTator, text mining | PubMed |
| Lung mitochondrial DNA copy number, inflammatory biomarkers, gene transcription and gene methylation in vapers and smokers. | EBioMedicine | 2022 | 36215783 | PubTator, text mining | PubMed |
| Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis. | BMC Genomics | 2022 | 36209057 | PubTator, text mining | PubMed |
| SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis. | EBioMedicine | 2022 | 36202053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4600/papers?page=24